Federal Register / Vol. 73, No. 189 / Monday, September 29, 2008 / Notices 56613 

the basic class of controlled substance 

listed. 

Dated: September 22, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–22878 Filed 9–26–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated March 11, 2008 and 

published in the Federal Register on 

March 19, 2008 (73 FR 14839), AllTech 

Associates Inc., 2051 Waukegan Road, 

Deerfield, Illinois 60015, made 

application to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of the basic classes of 

controlled substances listed in schedule 

II: 

Drug Schedule 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Hydrocodone (9193) ..................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

The company plans to import these 

controlled substances for the 

manufacture of reference standards. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

AllTech Associates Inc. to import the 

basic classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated AllTech 

Associates Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: September 22, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–22880 Filed 9–26–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated June 19, 2008 and 

published in the Federal Register on 

June 27, 2008 (73 FR 36572), Aptuit, 

10245 Hickman Mills Drive, Kansas 

City, Missouri 64137, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of Marihuana (7360), a basic 

class of controlled substance listed in 

schedule I. 

The company plans to import a 

finished pharmaceutical product 

containing cannabis extracts in dosage 

form for packaging for a clinical trial 

study. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Aptuit to import the basic class of 

controlled substance is consistent with 

the public interest, and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971, at this time. DEA 

has investigated Aptuit to ensure that 

the company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: September 22, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–22881 Filed 9–26–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated June 19, 2008 and 

published in the Federal Register on 

June 27, 2008 (73 FR 36571), Aptuit 

(Allendale) Inc., 75 Commerce Drive, 

Allendale, New Jersey 07401, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of 

Noroxymorphone (9668), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import the 

basic class of controlled substance for 

clinical trials and research. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Aptuit (Allendale) Inc. to import the 

basic classes of controlled substances is 

consistent with the public interest, and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated Aptuit 

(Allendale) Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: September 22, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–22882 Filed 9–26–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated March 19, 2008 and 

published in the Federal Register on 

March 28, 2008 (73 FR 16719), Alltech 

Associates Inc., 2051 Waukegan Road, 

Deerfield, Illinois 60015, made 

application to the Drug Enforcement 

Administration (DEA) to be registered as 

mstockstill on PROD1PC66 with NOTICES

56614 Federal Register / Vol. 73, No. 189 / Monday, September 29, 2008 / Notices 

a bulk manufacturer of the basic classes of controlled substances listed in 

schedules I and II: 

Drug Schedule 

Methcathinone (1237) .................................................................................................................................................................................. I 

N-Ethylamphetamine (1475) ........................................................................................................................................................................ I 

N,N-Dimethylamphetamine (1480) ............................................................................................................................................................... I 

4-Methylaminorex (cis isomer) (1590) ......................................................................................................................................................... I 

Alpha-ethyltryptamine (7249) ....................................................................................................................................................................... I 

Lysergic acid diethylamide (7315) ............................................................................................................................................................... I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ................................................................................................................................ I 

Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I 

Mescaline (7381) .......................................................................................................................................................................................... I 

4-Bromo-2,5-dimethoxyamphetamine (7391) ............................................................................................................................................... I 

4-Bromo-2,5-dimethoxyphenethylamine (7392) ........................................................................................................................................... I 

4-Methyl-2,5-dimethoxyamphetamine (7395) ............................................................................................................................................... I 

2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................. I 

2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................. I 

3,4-Methylenedioxyamphetamine (7400) ..................................................................................................................................................... I 

N-Hydroxy-3,4-methylenedioxyamphetamine (7402) ................................................................................................................................... I 

3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I 

3,4-Methylenedioxymethamphetamine (MDMA) (7405) .............................................................................................................................. I 

4-Methoxyamphetamine (7411) ................................................................................................................................................................... I 

Alpha-methyltryptamine (7432) .................................................................................................................................................................... I 

Bufotenine (7433) ......................................................................................................................................................................................... I 

Diethyltryptamine (7434) .............................................................................................................................................................................. I 

Dimethyltryptamine (7435) ........................................................................................................................................................................... I 

Psilocybin (7437) .......................................................................................................................................................................................... I 

Psilocyn (7438) ............................................................................................................................................................................................. I 

5-Methoxy-N,N-diisopropyltryptamine (7439) ............................................................................................................................................... I 

N-Ethyl-1-phenylcyclohexylamine (7455) ..................................................................................................................................................... I 

1-(1-Phenylcyclohexyl)pyrrolidine (7458) ..................................................................................................................................................... I 

1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. I 

1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ................................................................................................................................................ I 

Normorphine (9313) ..................................................................................................................................................................................... I 

Methamphetamine (1105) ............................................................................................................................................................................ II 

Phencyclidine (7471) .................................................................................................................................................................................... II 

Phenylacetone (8501) .................................................................................................................................................................................. II 

1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................. II 

Cocaine (9041) ............................................................................................................................................................................................. II 

Codeine (9050) ............................................................................................................................................................................................. II 

Dihydrocodeine (9120) ................................................................................................................................................................................. II 

Dihydromorphine (9145) ............................................................................................................................................................................... II 

Ecgonine (9180) ........................................................................................................................................................................................... II 

Meperidine intermediate-B (9233) ................................................................................................................................................................ II 

Noroxymorphone (9668) .............................................................................................................................................................................. II 

The company plans to manufacture 

high purity drug standards used for 

analytical applications only in clinical, 

toxicological, and forensic laboratories. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Alltech Associates, Inc. to manufacture 

the listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Alltech Associates Inc. to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: September 22, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–22875 Filed 9–26–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated April 28, 2008 and 

published in the Federal Register on 

May 2, 2008 (73 FR 24313), Lin Zhi 

International Inc., 687 North Pastoria 

Avenue, Sunnyvale, California 94085, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

.......................................................

Tetrahydrocannabinols (7370) ..... I 

3,4-Methylenedioxymethamphetamine (MDMA) (7405).I 

Cocaine (9041) ............................. II 

Oxycodone (9143) ........................ II 

Hydrocodone (9193) ..................... II 

Methadone (9250) ........................ II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

The company plans to manufacture 

the listed controlled substances as bulk 

reagents for use in drug abuse testing. 

mstockstill on PROD1PC66 with NOTICES